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pulmonary diseaseAbstract Arsenic is an element which occurs naturally in the earth’s crust and in small quantities
in rock, soil, water and air. Chronic arsenic toxicity produces various dermal and systemic manifes-
tations including cancer. It may also cause different pulmonary diseases. Here, we have described a
case series of three chronic arsenicosis patients having varied pulmonary involvements ranging from
bronchiectasis to chronic obstructive pulmonary diseases. They all had classic raindrop pigmenta-
tions with one patient developing squamous cell carcinoma. Pulmonary manifestations were severe
with more cutaneous manifestations as well as more arsenic levels in hair and nail samples of
patients. Manifestations also seemed severe with increased duration of exposure and more amount
of arsenic in their drinking water.
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B.V. All rights reserved.Introduction
Arsenic is an element which occurs naturally in the earth’s
crust and in small quantities in rock, soil, water and air.
Chronic arsenicosis has been deﬁned by the WHO working
group as a ‘chronic health condition arising from prolonged
ingestion (not less than 6 months) of arsenic above a safe dose,
usually manifested by characteristic skin lesions, with or
without involvement of internal organs’ [1]. Chronic arsenic
toxicity produces various dermal and systemic manifestations
including cancer [2]. It may also cause different pulmonarydiseases most probably by inﬂammation, rather than direct
toxicity [3]. Here, we have described a case series of three
patients with unique skin and pulmonary manifestations.
Case series
Case 1
A 25 year old female, a housewife, presented with hyperpig-
mented lesions all over the body, along with progressive
shortness of breath and cough. She had multiple, patchy,
hyperkeratotic lesions all over her body, predominantly on
palms and the plantar aspect of the feet since the past 10 years.
She suffered from respiratory distress off and on for about
6 months, which was increasing gradually, along with cough,d.
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Chest X ray showed bilateral ground glass opacity. Non-
contrast CT scan of the thorax revealed scattered bronchiecta-
sis and patchy alveolitis. Echocardiography showed early cor
pulmonale. Pulmonary function test revealed obstructive pat-
tern without bronchodilator reversibility. Serum angiotensin
converting enzyme level was 58.6 U/L, which was within nor-
mal limits. Fibreoptic bronchoscopy was done and bronchoal-
veolar lavage (BAL) ﬂuid was analyzed for cell count, cell type,
gram staining, ZN stain and BACTEC culture for mycobacte-
ria. All parameters were within normal limits. BAL ﬂuid was
also estimated for the arsenic level, which showed the arsenic
content in the ﬂuid was 0.02 lg/g.
Case 2
A 35 year-old male, farmer, presented with raindrop hyperpig-
mentation for the last 15 years, mostly concentrated on chest,
abdomen, upper and lower extremities and which were increas-
ing in number associated with occasional itching. On examina-
tion, multiple, raised keratosis (>2–5 mm), localized or patchy
pigmentation and leukomelanosis in which the hypopigmented
macules take a spotty, white appearance were evident. From,
last 4 years, he experienced dyspnoea and weakness along with
anorexia and erectile dysfunction. The dyspnea was initially
noticed only during exertion. However, it eventually became
noticeable with progressively less exertion or even at rest.
There was chronic cough, characterized by the insidious onset
of sputum production, which occurred in the morning. Chest
X ray showed increased radiolucency of the lung and air trap-
ping and the pulmonary function test, on the other hand,
revealed an obstructive pattern with FEV1/FVC result
<70%. He had no history of smoking and was diagnosed as
having chronic obstructive pulmonary disease (COPD) along
with chronic arsenicosis.
Case 3
A 40 year old male, porter, presented with multiple different-
sized hypo and hyperpigmented lesions all over the body. A
large 5 cm · 2 cm, oval shaped hypopigmented ulcer with
irregular margin and rolled-out edges was present just below
his left shoulder region and above the left axilla. Biopsy report
from that area showed the presence of tissue lined by keratin-
ised stratiﬁed squamous epithelium with focal thinning. Der-
mal appendages were reduced and replaced by collagen. The
report concluded the presence of squamous cell carcinoma.
The hyperpigmentation appeared in a ﬁnely freckled, ‘‘rain-
drop’’ pattern that is particularly pronounced on the trunk
and extremities and was symmetrically distributed bilaterally.
He also complained of worsening dyspnoea for the last 5 yearsTable 1 Patients’ characteristics and arsenic levels.
Patient Residence
(West Bengal) districts
Age (yrs)/Sex Arsenic con
drinking wa
1 24 Pg (N) 25/F 0.06
2 Murshidabad 32/M 0.13
3 24 Pg (S) 40/M 0.26and a history of acute exacerbations 2 times in the last 2 years
with subsequent hospital admissions. Chest X-ray and pul-
monary function tests conﬁrmed the presence of COPD and
he was being treated for the same with an inhaled bronchodi-
lator and steroids.Discussion
In West Bengal, a state of India, a large population is exposed
to arsenic contamination which is acquired from drinking
water, and which results in consequent escalation in the num-
ber of chronic arsenicosis cases [4]. While WHO permissible
limit of arsenic in ground water is known to be 0.01 mg/L, it
has been reported that in 8 districts of West Bengal covering
an area of about 34,000 km2 with a population of about 30
million, the arsenic content is much higher than the WHO
limit. It may be noted here that the Bureau of Indian Stan-
dards (BIS) has also revised the limit of arsenic in drinking
water from 0.05 to 0.01 mg/L (5–1 ppb) since 2003 [5].
For a case to be called chronic arsenicosis, two major crite-
ria are to be met (a) the presence of pigmentary and keratotic
skin lesions, and (b) evidence of exposure to elevated levels of
arsenic established by a history of intake of arsenic contami-
nated water, or by arsenic concentration in hair or nails [2].
Both nails and hairs provide circumstantial evidence of arsenic
exposure within the preceding 9 months [2].
Skin lesions have long been known to be hallmark signs of
chronic arsenic exposure. Hyperpigmentation and keratotic
lesions are the most common health effects found in popula-
tions exposed to arsenic-contaminated drinking water [4].
Non-healing ulcers may also develop which could progress
to malignancies [4]. In our case series, the skin manifestations
were non-malignant in two cases and malignant in the third
case. The hallmarks of non-malignant manifestations were der-
mal changes concomitantly characterized by increased pigmen-
tation and hardening of the skin, that is a combination of
melanosis and keratosis.
There were spotted or ‘‘raindrop pigmentation’’ present in
all three patients along with varied levels of hyperkeratotic
changes.
An epidemiological study from Chile ﬁrst suggested an
association with non-malignant respiratory changes [6] which
was conﬁrmed in West Bengal by a cross-sectional survey [7].
While an obstructive pattern was the predominant change
observed, restrictive pattern was also noted in a few. COPD
accounted for the largest group of patients, followed by inter-
stitial lung disease, malignancies and bronchiectasis [3]. In our
case series, one patient suffered from bronchiectasis and
remaining two from COPD. In another study, it was found
that persons with arsenicosis skin lesions have a 10-fold higher
rate of bronchiectasis [8]. The arsenic content in nail, hair andcentration in
ter (mg/L)
Duration of water
intake (yrs)
Arsenic level (lg/g)
Hair Nail
25 1.34 1.93
10 1.57 5.18
20 4.19 8.07
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tion of consumption of that drinking water (Table 1) are in
accordance with the fact that increasing degree of arsenic poi-
soning is directly correlated with worsening of lung function.
Thus, lung manifestations are more evident in those drinking
water with a higher arsenic content, and those with a worse
clinical and cutaneous symptoms [3]. All parameters of respira-
tory function were worse with a worsening degree of arsenic
poisoning.
The cause behind pulmonary involvement is probably
inﬂammatory. Increased activation of pulmonary macro-
phages as well as increased production of inﬂammatory medi-
ators (like tumor necrosis factor alpha, interleukin-1, LDH,
etc.) may be implicated for such manifestations [9].
All the three patients consumed drinking water from a
tube-well source for several years (Table 1) and had a family
history of similar skin manifestations. There were some epide-
miological studies on lung involvement in arsenicosis patients
[3,10] but the case series with different cutaneous and pulmon-
ary manifestations showing clearly that the positive correlation
of increased manifestations with an increased duration as well
as increased arsenic content of drinking water is scarce in the
literature and seemed to be interesting for medical fraternity.
No treatment of proven beneﬁt is currently available to
treat chronic arsenic toxicity, most are supportive therapy.
Thus, the provision of safe drinking water is a priority to pre-
vent these types of cutaneous along with pulmonary manifes-
tations. We have counseled the patients regarding the danger
of drinking arsenic-rich water and asked them to consume safe
drinking water as well as to come for regular check-up for their
diseases.
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